Kenny Dorsey v. Rockhard Laboratories LLC
2:13-cv-07557
C.D. Cal.Sep 19, 2014Background
- Plaintiff Kenny Dorsey bought "Rockhard Weekend" (RHW), a male sexual enhancement dietary supplement, and alleges packaging claimed it was a "sexual performance enhancer," "72-hour sexual performance pill," "Fast & Effective," "Doctor Tested/Approved," and "All Natural."
- Plaintiff alleges RHW’s formulations and packaging changed over time but the marketing message remained substantially the same.
- Plaintiff alleges none of RHW’s ingredients actually enhance male sexual performance and that he relied on the packaging when purchasing; he seeks to represent a putative class of purchasers.
- Claims pleaded: CLRA, UCL (fraudulent, unlawful, unfair), False Advertising, breach of express warranty, breach of implied warranty, and Magnuson-Moss Warranty Act violation.
- Defendants filed a Rule 12(b)(6) motion to dismiss on multiple grounds (standing/reliance, Rule 9(b) specificity, puffery, "All Natural," "Doctor Tested/Approved," FDCA preemption/applicability, UCL unfair prong, warranty notice, and MMWA applicability).
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Standing/reliance & injury | Dorsey read and relied on packaging and was injured because product lacks claimed effect | Dorsey didn’t plead which iteration he bought or specifics of non-performance | Court: Pleading sufficient — reliance and injury plausibly alleged despite not identifying exact iteration |
| Representative standing for other RHW iterations | Packaging/messages were substantially similar across iterations so Dorsey can represent those purchasers | Cannot represent purchasers of versions he didn’t buy | Court: Enough similarity at pleading stage; to be revisited at class certification |
| Fraud-based claims (UCL, FAL, CLRA) & Rule 9(b) | Packaging statements are specific, actionable misrepresentations not mere puffery; alleged falsity and consumer interpretations pleaded | Claims lack Rule 9(b) particularity; statements are puffery, "All Natural" and "Doctor Tested/Approved" not actionable | Court: Denied dismissal — statements pleaded with sufficient specificity; not mere puffery; "All Natural" and "Doctor Tested/Approved" plausibly misleading when read in context |
| FDCA/drug vs. dietary supplement argument | Dorsey: labeling as aphrodisiac/new drug requires FDA approval | Defendants: RHW is labeled a dietary supplement, not a drug, so FDA preapproval not required | Court: Dorsey failed to plausibly plead RHW is a drug; claims premised on lack of FDA approval are dismissed without leave to amend |
| UCL "unfair" prong | Dorsey alleges unfairness generally | Defendants say no unfair conduct pleaded | Court: UCL survives under "fraudulent" and "unlawful" prongs; UCL "unfair" prong dismissed for insufficient facts |
| Express/implied warranty & MMWA | Packaging promises performance; buyer gave notice impractical to manufacturer | Defendants: No pre-suit notice; statements are puffery; some labels are mere descriptions not warranties | Court: Warranty claims survive — notice excused as plaintiff bought from retailer; statements not mere puffery. MMWA claim valid as to performance-related promises; not valid as to "Doctor Tested/Approved" or "All Natural" as independent MMWA bases |
Key Cases Cited
- Ashcroft v. Iqbal, 556 U.S. 662 (plausibility standard for pleading)
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (plausibility and factual context for complaints)
- Williams v. Gerber Products Co., 552 F.3d 934 (reasonable consumer reliance; cannot expect consumer to find truth in ingredient list)
- Hinojos v. Kohl’s Corp., 718 F.3d 1098 (reliance in false advertising/consumer context)
- Vess v. Ciba-Geigy Corp. USA, 317 F.3d 1097 (Rule 9(b) requires who, what, when, where, how for fraud allegations)